Capital Advisors Wealth Management LLC Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Capital Advisors Wealth Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,773 shares of the healthcare conglomerate’s stock after purchasing an additional 135 shares during the period. Capital Advisors Wealth Management LLC’s holdings in UnitedHealth Group were worth $852,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Axiom Financial Strategies LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $210,000. McGowan Group Asset Management Inc. raised its position in UnitedHealth Group by 8.9% during the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in UnitedHealth Group by 31.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after purchasing an additional 60,300 shares during the last quarter. MAS Advisors LLC raised its position in UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after purchasing an additional 45 shares during the last quarter. Finally, First Western Trust Bank purchased a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $875,000. Institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

Shares of UnitedHealth Group stock opened at $486.06 on Tuesday. The firm has a market cap of $450.24 billion, a price-to-earnings ratio of 21.75, a PEG ratio of 1.43 and a beta of 0.66. The business has a 50-day moving average price of $492.05 and a 200-day moving average price of $486.73. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.68. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $558.10.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, topping the consensus estimate of $5.92 by $0.22. The company had revenue of $92.90 billion during the quarter, compared to analyst estimates of $90.97 billion. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The firm’s revenue was up 15.6% on a year-over-year basis. During the same quarter last year, the business posted $5.57 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 24.83 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be given a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 annualized dividend and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 33.65%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on UNH. Wells Fargo & Company cut their price target on UnitedHealth Group from $616.00 to $561.00 in a research note on Thursday, July 13th. Piper Sandler began coverage on UnitedHealth Group in a research note on Thursday, May 25th. They issued an “overweight” rating and a $580.00 price target on the stock. HSBC began coverage on UnitedHealth Group in a research report on Wednesday, September 6th. They issued a “hold” rating and a $540.00 price objective on the stock. Stephens reaffirmed an “overweight” rating and issued a $560.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 11th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $587.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 14th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $575.65.

Insider Activity

In other news, CEO Andrew Witty sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the transaction, the chief executive officer now owns 78,573 shares of the company’s stock, valued at $39,772,866.87. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.